Jack Nathan Medical Corp. (TSXV:JNH)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Jun 6, 2025, 2:44 PM EST
Jack Nathan Medical Income Statement
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 |
| -6.71 | 8.71 | 6.89 | 15.49 | 9.64 | 3.85 | |
Revenue Growth | - | 26.41% | -55.53% | 60.68% | 150.21% | 6.50% |
Cost of Revenue | -1.29 | 1.34 | 1.56 | 3.04 | 2.98 | 0.8 |
Gross Profit | -5.42 | 7.37 | 5.33 | 12.44 | 6.66 | 3.05 |
Selling, General & Admin | -5.33 | 9.47 | 6.57 | 15.45 | 9.67 | 2.77 |
Research & Development | - | - | - | - | 0.55 | 0.1 |
Amortization of Goodwill & Intangibles | - | - | - | - | 0.26 | 0.01 |
Operating Expenses | -5.96 | 9.76 | 7.51 | 17.64 | 13.2 | 3.86 |
Operating Income | 0.54 | -2.39 | -2.18 | -5.2 | -6.55 | -0.81 |
Interest Expense | - | -0.06 | -0.03 | -0.41 | -0.18 | -0.04 |
Interest & Investment Income | 1.58 | 0.04 | 0.06 | 0.01 | 0.04 | 0.02 |
Currency Exchange Gain (Loss) | 0.01 | -0.12 | 0.14 | 0.21 | -0.05 | -0.08 |
Other Non Operating Income (Expenses) | -1.65 | 0.02 | -0.12 | -0.14 | -0.36 | -0.07 |
EBT Excluding Unusual Items | 0.47 | -2.51 | -2.14 | -5.53 | -7.11 | -0.97 |
Merger & Restructuring Charges | - | - | - | -0.25 | -0.6 | -0.1 |
Impairment of Goodwill | - | - | - | -1.01 | -0.96 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.59 |
Asset Writedown | - | - | - | -0.4 | - | - |
Other Unusual Items | - | - | - | 0.2 | 0.43 | -8.63 |
Pretax Income | 0.47 | -2.51 | -2.14 | -6.99 | -8.23 | -10.29 |
Income Tax Expense | -0.09 | 0.02 | -0.81 | -0.09 | -0.22 | -0.38 |
Earnings From Continuing Operations | 0.56 | -2.53 | -1.33 | -6.9 | -8.02 | -9.91 |
Earnings From Discontinued Operations | 10 | 10 | -5.3 | - | - | - |
Net Income to Company | 10.56 | 7.46 | -6.64 | -6.9 | -8.02 | -9.91 |
Minority Interest in Earnings | - | - | - | - | 0.21 | 0.01 |
Net Income | 10.56 | 7.46 | -6.64 | -6.9 | -7.81 | -9.9 |
Net Income to Common | 10.56 | 7.46 | -6.64 | -6.9 | -7.81 | -9.9 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 87 | 87 | 86 | 84 | 82 | 52 |
Shares Outstanding (Diluted) | 87 | 87 | 86 | 84 | 82 | 52 |
Shares Change | 0.38% | 2.22% | 1.47% | 2.51% | 59.28% | 16.28% |
EPS (Basic) | 0.12 | 0.09 | -0.08 | -0.08 | -0.09 | -0.19 |
EPS (Diluted) | 0.11 | 0.08 | -0.08 | -0.08 | -0.10 | -0.19 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 |
Free Cash Flow | -2.45 | -7.54 | -10.2 | -4.59 | -5.29 | -1.31 |
Free Cash Flow Per Share | -0.03 | -0.09 | -0.12 | -0.05 | -0.06 | -0.03 |
Gross Margin | - | 84.66% | 77.39% | 80.34% | 69.05% | 79.19% |
Operating Margin | - | -27.45% | -31.71% | -33.57% | -67.95% | -20.91% |
Profit Margin | - | 85.74% | -96.35% | -44.57% | -81.00% | -257.05% |
Free Cash Flow Margin | - | -86.62% | -148.05% | -29.64% | -54.90% | -33.98% |
EBITDA | 0.69 | -1.54 | -1.29 | -4.41 | -6.1 | -0.7 |
EBITDA Margin | - | -17.68% | -18.79% | -28.49% | -63.33% | -18.19% |
D&A For EBITDA | 0.15 | 0.85 | 0.89 | 0.79 | 0.44 | 0.1 |
EBIT | 0.54 | -2.39 | -2.18 | -5.2 | -6.55 | -0.81 |
EBIT Margin | - | -27.45% | -31.71% | -33.57% | -67.95% | -20.91% |
Advertising Expenses | - | 0.26 | 0.38 | 0.26 | 0.43 | 0.24 |